ANTIEMETICS IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY - A DOUBLE-BLIND PROSPECTIVE RANDOMIZED STUDY COMPARING METOCLOPRAMIDE WITH CHLORPROMAZINE

被引:32
作者
GRAHAMPOLE, J [1 ]
WEARE, J [1 ]
ENGEL, S [1 ]
GARDNER, R [1 ]
MEHTA, P [1 ]
GROSS, S [1 ]
机构
[1] UNIV FLORIDA,COLL MED,DEPT PEDIAT,DIV HEMATOL ONCOL,GAINESVILLE,FL 32611
关键词
D O I
10.1200/JCO.1986.4.7.1110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1110 / 1113
页数:4
相关论文
共 17 条
[1]   METOCLOPRAMIDE - DOSE-RELATED TOXICITY AND PRELIMINARY ANTIEMETIC STUDIES IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY [J].
ALLEN, JC ;
GRALLA, R ;
REILLY, L ;
KELLICK, M ;
YOUNG, C .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1136-1141
[2]   ADVANCES IN ANTI-EMETIC THERAPY [J].
BAKOWSKI, MT .
CANCER TREATMENT REVIEWS, 1984, 11 (03) :237-256
[3]   DYSTONIC REACTIONS AND THE PHARMACOKINETICS OF METOCLOPRAMIDE IN CHILDREN [J].
BATEMAN, DN ;
CRAFT, AW ;
NICHOLSON, E ;
PEARSON, ADJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (05) :557-559
[4]   A COMPARISON OF THE ANTIEMETIC EFFICACY OF PROCHLORPERAZINE AND METOCLOPRAMIDE FOR THE TREATMENT OF CISPLATIN-INDUCED EMESIS - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY [J].
CARR, BI ;
BERTRAND, M ;
BROWNING, S ;
DOROSHOW, JH ;
PRESANT, C ;
PULONE, B ;
HILL, LR .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1127-1132
[5]  
ENGEL S, 1983, PEDIATR RES S, V17, pA233
[6]   ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
GRALLA, RJ ;
ITRI, LM ;
PISKO, SE ;
SQUILLANTE, AE ;
KELSEN, DP ;
BRAUN, DW ;
BORDIN, LA ;
BRAUN, TJ ;
YOUNG, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909
[7]   METOCLOPRAMIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE [J].
HARRINGTON, RA ;
HAMILTON, CW ;
BROGDEN, RN ;
LINKEWICH, JA ;
ROMANKIEWICZ, JA ;
HEEL, RC .
DRUGS, 1983, 25 (05) :451-494
[8]  
JUSTINBESANCON L, 1964, CR SOC BIOL, V158, P723
[9]  
KRIS MG, 1985, CANCER, V55, P527, DOI 10.1002/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO
[10]  
2-2